Literature DB >> 26778773

NFκB-inducing kinase inhibits NFκB activity specifically in neurons of the CNS.

Xianrong Mao1, Bounleut Phanavanh2, Hamdan Hamdan3, Andréa M Moerman-Herzog2, Steven W Barger2,4,5.   

Abstract

The control of NFκB in CNS neurons appears to differ from that in other cell types. Studies have reported induction of NFκB in neuronal cultures and immunostaining in vivo, but others have consistently detected little or no transcriptional activation by NFκB in brain neurons. To test if neurons lack some component of the signal transduction system for NFκB activation, we transfected cortical neurons with several members of this signaling system along with a luciferase-based NFκB-reporter plasmid; RelA was cotransfected in some conditions. No component of the NFκB pathway was permissive for endogenous NFκB activity, and none stimulated the activity of exogenous RelA. Surprisingly, however, the latter was inhibited by cotransfection of NFκB-inducing kinase (NIK). Fluorescence imaging of RelA indicated that co-expression of NIK sequestered RelA in the cytoplasm, similar to the effect of IκBα. NIK-knockout mice showed elevated expression of an NFκB-reporter construct in neurons in vivo. Cortical neurons cultured from NIK-knockout mice showed elevated expression of an NFκB-reporter transgene. Consistent with data from other cell types, a C-terminal fragment of NIK suppressed RelA activity in astrocytes as well as neurons. Therefore, the inhibitory ability of the NIK C-terminus was unbiased with regard to cell type. However, inhibition of NFκB by full-length NIK is a novel outcome that appears to be specific to CNS neurons. This has implications for unique aspects of transcription in the CNS, perhaps relevant to aspects of development, neuroplasticity, and neuroinflammation. Full-length NIK was found to inhibit (down arrow) transcriptional activation of NFκB in neurons, while it elevated (up arrow) activity in astrocytes. Deletion constructs corresponding to the N-terminus or C-terminus also inhibited NFκB in neurons, while only the C-terminus did so in astrocytes. One possible explanation is that the inhibition in neurons occurs via two different mechanisms, including the potential for a neuron-specific protein (e.g., one of the 14-3-3 class) to create a novel complex in neurons, whereas the C-terminus may interact directly with NFκB. [Structure of NIK is based on Liu J., Sudom A., Min X., Cao Z., Gao X., Ayres M., Lee F., Cao P., Johnstone S., Plotnikova O., Walker N., Chen G., and Wang Z. (2012) Structure of the nuclear factor κB-inducing kinase (NIK) kinase domain reveals a constitutively active conformation. J Biol Chem. 287, 27326-27334); N-terminal lobe is oriented at top].
© 2016 International Society for Neurochemistry.

Entities:  

Keywords:  MAP3K14; NFκB; RelA; luciferase; transcription; β-galactosidase

Mesh:

Substances:

Year:  2016        PMID: 26778773      PMCID: PMC5115916          DOI: 10.1111/jnc.13526

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  43 in total

1.  Negative regulation of the nuclear factor kappa B-inducing kinase by a cis-acting domain.

Authors:  G Xiao; S C Sun
Journal:  J Biol Chem       Date:  2000-07-14       Impact factor: 5.157

2.  The NF-kappa B-inducing kinase induces PC12 cell differentiation and prevents apoptosis.

Authors:  E D Foehr; J Bohuslav; L F Chen; C DeNoronha; R Geleziunas; X Lin; A O'Mahony; W C Greene
Journal:  J Biol Chem       Date:  2000-11-03       Impact factor: 5.157

3.  Respiratory syncytial virus influences NF-kappaB-dependent gene expression through a novel pathway involving MAP3K14/NIK expression and nuclear complex formation with NF-kappaB2.

Authors:  Sanjeev Choudhary; Steve Boldogh; Roberto Garofalo; Mohammad Jamaluddin; Allan R Brasier
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

Review 4.  The noncanonical NF-κB pathway.

Authors:  Shao-Cong Sun
Journal:  Immunol Rev       Date:  2012-03       Impact factor: 12.988

5.  Identification of a novel A20-binding inhibitor of nuclear factor-kappa B activation termed ABIN-2.

Authors:  S Van Huffel; F Delaei; K Heyninck; D De Valck; R Beyaert
Journal:  J Biol Chem       Date:  2001-06-04       Impact factor: 5.157

6.  Inhibition of AMPA responses by mutated presenilin 1.

Authors:  A M Moerman; S W Barger
Journal:  J Neurosci Res       Date:  1999-09-15       Impact factor: 4.164

7.  Induction of p100 processing by NF-kappaB-inducing kinase involves docking IkappaB kinase alpha (IKKalpha) to p100 and IKKalpha-mediated phosphorylation.

Authors:  Gutian Xiao; Abraham Fong; Shao-Cong Sun
Journal:  J Biol Chem       Date:  2004-05-11       Impact factor: 5.157

8.  Differential regulation of Mn-superoxide dismutase in neurons and astroglia by HIV-1 gp120: Implications for HIV-associated dementia.

Authors:  Ramendra N Saha; Kalipada Pahan
Journal:  Free Radic Biol Med       Date:  2007-03-31       Impact factor: 7.376

9.  Structure-function relationship of cytoplasmic and nuclear IκB proteins: an in silico analysis.

Authors:  Balachandran Manavalan; Shaherin Basith; Yong-Min Choi; Gwang Lee; Sangdun Choi
Journal:  PLoS One       Date:  2010-12-23       Impact factor: 3.240

10.  The zinc finger protein A20 inhibits TNF-induced NF-kappaB-dependent gene expression by interfering with an RIP- or TRAF2-mediated transactivation signal and directly binds to a novel NF-kappaB-inhibiting protein ABIN.

Authors:  K Heyninck; D De Valck; W Vanden Berghe; W Van Criekinge; R Contreras; W Fiers; G Haegeman; R Beyaert
Journal:  J Cell Biol       Date:  1999-06-28       Impact factor: 10.539

View more
  6 in total

Review 1.  Checks and balances: The glucocorticoid receptor and NFĸB in good times and bad.

Authors:  Mandakh Bekhbat; Sydney A Rowson; Gretchen N Neigh
Journal:  Front Neuroendocrinol       Date:  2017-05-11       Impact factor: 8.606

Review 2.  Gene regulation and genetics in neurochemistry, past to future.

Authors:  Steven W Barger
Journal:  J Neurochem       Date:  2016-10-17       Impact factor: 5.372

3.  Meta-Analysis of MicroRNAs Dysregulated in the Hippocampal Dentate Gyrus of Animal Models of Epilepsy.

Authors:  Prashant K Srivastava; Paolo Roncon; Katarzyna Lukasiuk; Jan A Gorter; Eleonora Aronica; Asla Pitkänen; Enrico Petretto; Michael R Johnson; Michele Simonato
Journal:  eNeuro       Date:  2017-12-28

4.  Stabilization of NF-κB-Inducing Kinase Suppresses MLL-AF9-Induced Acute Myeloid Leukemia.

Authors:  Yan Xiu; Qianze Dong; Qingchang Li; Fengyin Li; Nick Borcherding; Weizhou Zhang; Brendan Boyce; Hai-Hui Xue; Chen Zhao
Journal:  Cell Rep       Date:  2018-01-09       Impact factor: 9.423

5.  Palmitic Acid-BSA enhances Amyloid-β production through GPR40-mediated dual pathways in neuronal cells: Involvement of the Akt/mTOR/HIF-1α and Akt/NF-κB pathways.

Authors:  Jeong Yeon Kim; Hyun Jik Lee; Sei-Jung Lee; Young Hyun Jung; Dae Young Yoo; In Koo Hwang; Je Kyung Seong; Jung Min Ryu; Ho Jae Han
Journal:  Sci Rep       Date:  2017-06-28       Impact factor: 4.379

Review 6.  Shared (epi)genomic background connecting neurodegenerative diseases and type 2 diabetes.

Authors:  Valerio Caputo; Andrea Termine; Claudia Strafella; Emiliano Giardina; Raffaella Cascella
Journal:  World J Diabetes       Date:  2020-05-15
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.